Vol.17 No.21, May 30, 2024
Kwang Kee Kim, Jung JeKarl, Minjoo Choi, Eunsil Cheon, Heewon Kang, Jihee Kim, Sunhye Choi, Kyungwon Oh
Public Health Weekly Report 2024; 17(21): 877-902 https://doi.org/10.56786/PHWR.2024.17.21.1One of the major functions of public health should be monitoring levels of alcohol consumption and the changes over time. However, little attention has been paid to the changing trends in alcohol consumption in the social context. The study aim was to describe alcohol consumption levels for the period 1998–2021 in terms of the monthly prevalence of alcohol use (MPA) and the prevalence of high-risk alcohol use (PHA). Additionally, change trends were broken down by age, period, and cohort effect. The study used data from Korea’s National Health and Nutrition Examination Survey from 1998 to 2021. The data showed a differential pattern of change in both MPA and PHA between gender, with men tending to exhibit a decrease or remaining at a plateau. However, women exhibited a discernible increase in both MPA and PHA. A convergence theory of drinking behavior between gender has been confirmed among Korean adults. Age-period-cohort models identify the effects of age, with both MPA and PHA reaching the highest rates at age 45 years and then declining among both men and women. During the period 2009–2011 and around 2015, the relative risk (RR) of the likelihood of MPA and PHA was higher than the RR in any other year studied, which indicates a period effect. In addition, birth cohort effects were observed in MPA and PHA among adults, with more discernible patterns in women. Policy implications were discussed with the aim of reducing harm caused by alcohol use, with a high policy priority placed on the reduction of alcohol use among women.
Sanghee Park, Sangho Choi, Se-Mi Jeon, Seonghan Kim
Public Health Weekly Report 2024; 17(21): 903-915 https://doi.org/10.56786/PHWR.2024.17.21.2Nontuberculous mycobacteria (NTM) are mycobacteria other than the Mycobacterium tuberculosis complex and Mycobacterium leprae. Pulmonary infections are the most common clinical manifestation of NTM infections. The incidence and medical costs associated with NTM pulmonary disease are increasing in the Republic of Korea. Despite a multidrug regimen and a long course of therapy, NTM treatment has problems with treatment decisions, drug side effects, low treatment success rates, and recurrence. Research on NTM treatment has focused on repurposing existing antibiotics and developing new targeted drugs to address these problems. In this review, we introduce the current status of research on NTM drugs and provide opinions on the direction of research for eradicating NTM infections.
Myung-Jae Hwang, So Yeon Park, Hyungjun Kim, Se Jeong Yang, Sungchan Yang, Jin Seon Yang
Public Health Weekly Report 2025;18: 17-32 https://doi.org/10.56786/PHWR.2025.18.1.2Hyewook Hwang, Wookeon Lee, Seohyeon Ahn, Young-Sook Choi, Seunghyun Lewis Kwon, Dongwoo Lee, Eun Hwa Choi, SokGoo Lee
Public Health Weekly Report 2025;18: 90-102 https://doi.org/10.56786/PHWR.2025.18.2.3+82-43-719-7569